Showing results (161-170 of 221) with videos related to

Sort By:
Pageof 23
Oncogene|September 1, 1999
c-Myc does not prevent glucocorticoid-induced apoptosis of human leukemic lymphoblastsM Löffler, M J Ausserlechner, M Tonko, et al.
Oncogene|August 13, 1999
A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancerV Shridhar, J Staub, B Huntley, et al.
Cancer Genetics and Cytogenetics|November 1, 1993
Cytogenetic studies of epithelial ovarian carcinomaR B Jenkins, D Bartelt, P Stalboerger, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2009
Physical function in older candidates for renal transplantation: an impaired populationErica L Hartmann, Dalane Kitzman, Michael Rocco, et al.
Cancer Research|May 15, 1993
Human epithelial ovarian cancer allelotypeW Cliby, S Ritland, L Hartmann, et al.
FEBS Letters|January 27, 1997
The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cellsS Geley, B L Hartmann, K Kapelari, et al.
Oncogene|March 3, 1998
Frequent homozygous deletions in the FRA3B region in tumor cell lines still leave the FHIT exons intactL Wang, J Darling, J S Zhang, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 2, 2003
Application of MINERVA Monte Carlo simulations to targeted radionuclide therapyMarie-Anne Descalle, Christine L Hartmann Siantar, Lucile Dauffy, et al.
Medical Physics|August 6, 1999
Correlated histogram representation of Monte Carlo derived medical accelerator photon-output phase spaceA E Schach von Wittenau, L J Cox, P M Bergstrom, et al.
Genes, Chromosomes & Cancer|January 19, 1999
Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancerH Huang, C P Reed, A Mordi, et al.
Pageof 23